GL1X · GenesisL1 explorer

MolNFT v1 · #378138 · protein

AlphaFold monomer V2.0 prediction for dual-specificity RNA methyltransferase rlmn (B0CII9)

B0CII9: “AlphaFold monomer V2.0 prediction for dual-specificity RNA methyltransferase rlmn (B0CII9)”. 1 pocket (best druggability 0.80). MolNFT v1 #378138 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

Accession
B0CII9
Type
protein
Length
411 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0x025f3b1a898b05AD2731bE6Ab72687b5920c4A3F
Molecule
Dual-specificity RNA methyltransferase rlmn
UniProt
B0CII9
Pockets
1 · best druggability 0.80

Structure

1 distinct chain · 39% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ADual-specificity RNA methyltransferase rlmnprotein41139% helix, 17% strandB0CII9

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15590.800.8663empty

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.